Medtronic (MDT) Change in Accured Expenses (2014 - 2026)

Medtronic has disclosed Change in Accured Expenses across 13 years of filings, most recently posting -$531.0 million for Q3 2026.

• In Q3 2026, Change in Accured Expenses rose 11.2% year-over-year to -$531.0 million; the TTM figure through Jul 2026 stood at $113.0 million (down 47.44% YoY), while the FY2026 annual figure was $46.0 million, down 77.99% from the prior year.
• Change in Accured Expenses came in at -$531.0 million for Q3 2026 at Medtronic, down from $123.0 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $703.0 million in Q1 2026 to a low of -$673.0 million in Q3 2023.
• Average Change in Accured Expenses over 5 years is $77.4 million, with a median of $133.0 million recorded in 2022.
• Year-over-year, Change in Accured Expenses surged 10250.0% in 2022 and tumbled 357.82% in 2023.
• Over 5 years, Change in Accured Expenses stood at $133.0 million in 2022, then plunged by 119.55% to -$26.0 million in 2023, then slumped by 296.15% to -$103.0 million in 2024, then tumbled by 76.7% to -$182.0 million in 2025, then plunged by 191.76% to -$531.0 million in 2026.
• Per Business Quant data, the three most recent Change in Accured Expenses figures were -$531.0 million in Q3 2026, $123.0 million in Q2 2026, and $703.0 million in Q1 2026.